Daré Bioscience, Inc.
NASDAQ:DARE
4.03 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -30.161 | -30.948 | -38.696 | -27.401 | -14.264 | -16.739 | -11.503 | -39.305 | -39.594 | -23.342 | -17.143 | -22.101 |
| Depreciation & Amortization
| 0.038 | 0.024 | 0.026 | 0.043 | 0.011 | 0.002 | 0 | 0.261 | 0.192 | 0.126 | 0.197 | 0.346 |
| Deferred Income Tax
| -0.496 | 0 | -0.37 | 0 | 0 | 0 | 0 | -0.503 | 0.733 | 2.465 | 0.007 | 0.002 |
| Stock Based Compensation
| 2.531 | 2.159 | 1.6 | 0.742 | 0.462 | 0.139 | 0.016 | 2.755 | 2.375 | 0.885 | 0.622 | 0.529 |
| Change In Working Capital
| -11.343 | 10.7 | 8.728 | 1.543 | 0.706 | 0.634 | 1.139 | -2.317 | 4.42 | 0.864 | -0.682 | 0.265 |
| Accounts Receivables
| 0.754 | -0.558 | -0.685 | 0.095 | -0.201 | 0.253 | 0.662 | -0.446 | 0.342 | -0.713 | -0.229 | -0.061 |
| Inventory
| 0 | 0.558 | 0.685 | -0.095 | 0.201 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 1.358 | -0.075 | 1.082 | -0.062 | 0.609 | 0.151 | 0.753 | -0.603 | 0.795 | 0.341 | 0.014 | -0.163 |
| Other Working Capital
| -13.454 | 10.775 | 7.646 | 1.605 | 0.098 | 0.483 | 0.386 | -1.268 | 3.283 | 1.236 | -0.467 | 0.489 |
| Other Non Cash Items
| 0.574 | -0.023 | -0.052 | -0.162 | -0.231 | 5.695 | 7.808 | 5.573 | -0.041 | -0.059 | 0.385 | -0.046 |
| Operating Cash Flow
| -38.857 | -18.088 | -28.764 | -25.235 | -13.315 | -10.268 | -2.54 | -33.536 | -31.915 | -19.061 | -16.614 | -21.005 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -0.629 | -0.063 | -0.015 | -0.018 | 0 | -0.012 | 0 | -0.535 | -0.277 | -0.225 | -0.007 | -0.18 |
| Acquisitions Net
| 0 | 925 | 925 | 0 | 6.144 | -0.507 | 9.918 | 0 | 0.023 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.23 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.117 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | -925 | -925 | 0 | 6,143.893 | -0.507 | 9.918 | 0.117 | -0.207 | 0.04 | 0 | 0 |
| Investing Cash Flow
| -0.629 | -0.063 | -0.015 | -0.018 | 6.144 | -0.519 | 9.918 | -0.418 | -0.484 | -0.185 | -0.007 | -0.18 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -4.991 | 0 | 0 | -0.367 | 0 | 0 | -0.155 | -7.922 | -3.321 | -3.348 | -3.084 | -0.379 |
| Common Stock Issued
| 10.646 | 1.219 | 75.314 | 22.977 | 5.152 | 10.112 | 0 | 0.918 | 39.813 | 60.002 | 0.035 | 0.003 |
| Common Stock Repurchased
| 0 | 0 | 0 | -0.367 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | -6.863 | -789.594 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 4.724 | 0.125 | 0.533 | 9.751 | 789.594 | 10.112 | 0.155 | 0.198 | 20.641 | 8.278 | 8.451 | 22.923 |
| Financing Cash Flow
| 15.637 | 1.343 | 75.847 | 25.131 | 5.152 | 10.112 | 0.155 | -7.004 | 57.133 | 64.932 | 5.402 | 22.547 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| -0.01 | -0.196 | -0.064 | 0.011 | -0.006 | -0.079 | -0.018 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -24.194 | -17.004 | 47.005 | -0.111 | -2.026 | -0.754 | 7.515 | -40.958 | 24.734 | 45.686 | -11.219 | 1.362 |
| Cash At End Of Period
| 10.476 | 34.67 | 51.674 | 4.669 | 4.78 | 6.806 | 7.56 | 34.95 | 75.908 | 51.174 | 5.488 | 16.707 |